Abstract -Of the many risk factors suggested for sudden unexpected death in epilepsy (SUDEP), higher frequency of seizures is a very consistent issue. Following this reasoning, it has been established that hemodialysis-associated seizure is a complication of dialysis procedure. Based on these facts, this study investigated a possible association between cardiovascular abnormalities and SUDEP among patients with chronic renal insufficiency in regular hemodialysis program. For that, a retrospective medical history of 209 patients was reviewed to investigate the occurrence of convulsive seizures and EKG abnormalities during dialytic program. Three patients presented generalized tonic-clonic seizures, one had partial seizure with secondary generalization, and one presented unclassified seizure. Any EKG abnormalities and SUDEP event were found in all patients evaluated. In conclusion, the present findings demonstrated uncommon the occurrence of seizures and also SUDEP. Probably, the main justification to not allow us to demonstrated a direct relation between SUDEP and cardiovascular diseases in hemodialysis are the reduced number of cases examined.
Sudden death in epilepsy Gomes et al.
Approximately epilepsy is the most common serious neurological condition and almost 50 million people worldwide have epilepsy [1] [2] [3] . The most common risk factors for epilepsy are cerebrovascular diseases, brain tumours, alcohol, traumatic head injuries, malformations of cortical development, genetic inheritance and infections of the central nervous system 4 . In resource-poor countries, endemic infections, such as malaria and neurocysticercosis seem to be major risk factors 5 . Actually, clinical data support that people with epilepsy are two-to three-fold increase to die prematurely than those without epilepsy and the most common epilepsy-related category of death is sudden unexpected death in epilepsy (SUDEP) 6, 7 . Information concerning risk factors for SUDEP is conflicting, but potential risk factors include: age, early onset of epilepsy, duration of epilepsy, uncontrolled seizures, seizure frequency, seizure type, antiepileptic drugs number and winter temperatures 6 . Additionally, the underlying pathophysiology of SUDEP is unknown; however, it is very probable that cardiac arrhythmia play a potential role. In this way, rugg-Gunn and collaborators 8 using implantable loop recorders demonstrated that some patients with refractory partial epilepsy may have potentially life-threatening cardiac arrhythmias. Moreover, it has been established that repetitive seizures can alter the regulation of cardiac activity by the autonomic nervous system (ANS), and ANS dysregulation is thought to be associated with higher morbidity and mortality in patients with epilepsy 9 . In accordance with this reasoning, we postulated the question: is there a possible relation between epilepsy, renal dysfunction, cardiovascular abnormalities and hence SUDEP?
Cardiac disease is the major cause of death in patients with end-stage of renal disease, accounting for approximately 43% of all deaths 10, 11 . In dialysis patients, about 20% of cardiac deaths are attributed to acute myocardial infarction, a catastrophic clinical event in this group of patients 10, 12 . In parallel, it has been reported an estimated incidence of seizure of approximately 10% in patients with chronic renal failure 13 . In addition, Plum and Posner 14 also noted that convulsions occurred in one third of patients with end-stage renal disease (ESrD) and was frequently a preterminal event. The seizures in these series usually were generalized tonic-clonic type; however, the mechanism of reduced seizure threshold in renal failure is still unknown. hemodialysis-associated seizure (hAS) is a common complication of hemodialysis 15 . hAS occurs in 7% to 50% of children with ESrD, and their seizures are usually reported as generalized tonic-clonic seizures 16 . risk factors for hAS include young age, prior history of seizures, malignant hypertension, microvascular diseases, uremic encephalopathy and cardiomyopathy. Moreover, induced brain water disequilibrium, hypocalcaemia, uremic toxins, the use of acetate in the dialysate, intracranial hemorrhage due to systemic heparinization, treatment with recombinant erythropoietin, hemodynamic and metabolic defects, and drugs such as penicillin and theophilline are also considered responsible for hAS [16] [17] [18] . If all these data are taken together, information on the management of seizures in renal failure should be disseminated among professionals treating systemic diseases. Based on these facts, we are interested here in exploring the occurrence of epilepsy and hence sudden unexpected death in patients with chronic renal insufficiency under regular hemodialysis program.
METHOD
A retrospective medical history of 209 patients was reviewed to investigate the occurrence epilepsy, cardiovascular abnormalities and hence sudden unexpected death in dialysis patients at the Nephrology Institute of Mogi das Cruzes. From 209 patients under dialytic treatment, 7 had suffered some type of convulsive seizure and were invited to participate in the study, but only 5 patients had agreed to participate. They were 4 males and 1 female, with a mean age of 42 years (range: 20 to 72 years old). The five patients have severe systemic arterial hypertension and were using antihypertensive drugs. In our clinic, all patients have monthly evaluation of total calcium and were receiving calcium carbonate (CaCO 3 ). The solution for the dialytic treatment contains 210.7g/l of NaCl, with a calcium concentration of 2.5 or 3.5 mEq/l.
All patients were evaluated for initial disease, duration, type and frequency of hAS and then submitted to clinical and neurological examination. The mean time of dialysis treatment and the electroencephalography (EEG) was analysed in all patients. The seizures were classified according the Commission on Classification and Terminology of International league Against Epilepsy 19 . The possible seizure triggering factors, such as the use or withdrawal of medications, sleep deprivation, arterial hypertension, infections, and electrolytic misbalance, especially hypocalcaemia, were also investigated.
EKG data for all patients was obtained from one or two EKG channels (used routinely at our center) utilizing two EKG electrodes. EKG electrodes were usually placed on the anterior chest, one on each side, though exact positioning was not standardized. EKG abnormalities were reviewed by a board certified physician (rAG, Director of the Nephrology Institute of Mogi das Cruzes). we would like to point out that part of the data used in the present study have already been published in a previous work developed by our research group 20 . The study received approval from the human research Ethics Committee, and all subjects signed an informed consent document.
RESULTS
In our study we analyzed the data of 5 out of 209 patients recruited under dialytic treatment at the Nephrology Institute of Mogi das Cruzes. All five patients had se-vere systemic arterial hypertension and were using antihypertensive drugs. These patients were also using antiepileptic drug (phenytoin 200 mg/daily) and CaCO3 (1.500 mg/daily). The mean age of beginning of dialysis was 25 years. The mean duration of dialytic treatment was 5.8 years (range: 2 to 12 years). The causes of renal failure were diabetic nephropathy (4 patients) and chronic glomerolonephritis (1 patient) ( Table 1 ). All patients had normal aluminum plasma levels and were not affected by other clinical pictures that could be led to possible aluminum intoxication. The signs of Chvostek and Trousseau were absent in all patients and the neurological examination was normal in 4 patients, but one presented pyramidal syndrome (left hemiparesia with pyramidal signs), with abnormal CT scan (hipodensity on right temporal lobe).
The seizure history of the five patients is listed on Table 2. Briefly, three patients presented generalized tonic-clonic seizures, one presented partial seizure with secondary generalization, and one presented unclassified seizure. All patients had seizures at home, two patients had seizures during dialysis procedure and one of them had presented convulsive status epilepticus. Two patients had already presented seizures prior the beginning of dialysis treatment; one of them without detectable structural CNS lesion, and the other showed hipodensity on right temporal lobe (vascular cerebral disease). All patients presented normal interictal EEG. At time of seizure, none of them presented infection, electrolytic misbalance (hypocalcemia), sleep deprivation, stress situation or were using pharmacological agents that lower the seizure threshold and can cause seizures, such as theophylline, antipsychotics and antidepressants. Any EKG abnormality and serious abnormalities were found in all patients evaluated by a board certified physician.
DISCUSSION
The primary aim of this study was to verify the possible association between epilepsy and hence sudden unexpected death in patients with chronic renal insufficiency under regular hemodialysis program. we note the cases evaluated (5 out of 209) that cardiovascular alterations and hence SUDEP is not a common event. Nevertheless, these findings need to be interpreted with caution. The study has methodological limitations; however, as research in this field must be guided by the potential for the prevention of SUDEP, a number of arguments might be put forward.
Firstly, it has long been believed that seizures are relatively a common complication of hemodialysis 15 . however, in our study we observed the occurrence of hAS in only 2% of our patients. In these lines, our results are not in agreement with previous studies, which related an estimated incidence of seizure of approximately 10% in patients with chronic renal failure 13 . Concerning the smaller occurrence of seizures in our patients and the no presence of SUDEP among them, we can pointed here that of the many risk factors suggested for SUDEP, higher frequency of seizures is a very consistent issue. Accordingly, among the rarely witnessed cases of SUDEP, the majority of patients proved to suffer a partial or generalized seizure immediately prior to death, suggesting a seizure-related cardiac or respiratory dysfunction 21 . Moreover, SUDEP is a rare event in patients in remission and only few such cases have been described 22, 23 . In an elegant largest case-control study, Nilsson and colleagues demonstrated that seizure frequency is a strongest risk factor for SUDEP 24 . In their study, 57 SUDEP cases were included, of whom 91% had undergone necropsy. The relative risk of SUDEP increased with number of seizures per year and the estimated relative risk was 10.16 (95% CI 2.94-35.18) in patients with more than 50 seizures per year, compared with those with up to two seizures per year.
with regard the second argument, in spite of reports that prior history of seizure did influence the risk of seizures among patients receiving hemodialysis 16 , we did not observe higher risk in our patients who had prior history of epilepsy. It is difficult to make comparisons between our with other studies since different factors may influence the analysis, such as the age of the subjects, type of seizures and risk factors for hAS as previously mentioned. In the same way and thinking about no presence of SUDEP in our study, it has been known that SUDEP appears to be an issue mainly in patients with chronic epilepsy 22 . we note in all cases evaluated (5 out of 209) that only two patients had already presented isolated seizures prior the beginning of dialysis treatment, not characterizing long duration of epilepsy in these cases. Our results are in agreement with previous studies that report a mean duration of the seizure disorder ranging from 15 to 20 years in SUDEP cases 22 . Third, SUDEP is usually unwitnessed, but when witnessed, all studies that have identified the patients' seizure type report a history of primary or secondary generalized tonic-clonic seizures (GTCS) in at least 90% of SUDEP cases 22, 25 . Although three patients presented GTCS in our study, these seizures were isolated and no SUDEP cases were found. Following this reasoning, our results are totally in agreement with the elegant study of Birnbach and colleagues that comparing people with epilepsy who died with those who survived, described that majority of those who died had a history of GTSC and that the frequency of GTCS was greater in those who died 26 . Finally, age is another interesting risk factor for SUDEP that could be explored in our study. The age of reported cases of SUDEP have ranged from 8 months to 83 years, however, the great majority of studies have been shown that mean ages of SUDEP range from 26 to 37 years 21, 22, 25, 27 . In these lines, one explanation about the reason that we did not find SUDEP cases in our study is because the age of each patient evaluated by us is not related with the mean age of SUDEP occurrence. Moreover, it is important to note that some studies have found different decades of peak of incidence of SUDEP 25 and although our study did not associated the relation between age and SUDEP, we could not make statements concerning the SUDEP risk factor related to age in our cases for epileptic population in general.
In conclusion, the results of present study are totally in agreement with our earlier research, demonstrating that seizures in renal failure continuous been considered an occasional event that does not usually become chronic 20 . In this sense, we are sure that information on the management of seizures in renal failure and the possibility of SUDEP occurrence among patients with endstage of renal disease should be disseminated among professionals treating systemic diseases. In sum, we also believe that neurologist should be aware about cardiovascular abnormalities and hence SUDEP in patients with epilepsy receiving renal replacement therapy with dialysis and recommend these patients to be submitted to a cardiological investigation. Strategies, such as taking a detailed cardiovascular history, looking for cardiovascular disease, symptoms, cardiovascular risk factors and prior cardiac findings (electrocardiogram, echocardiogram and holter monitoring) should be developed by a cardiologist or a general practioner and assess if this could prevent SUDEP although this may require large populational studies 28 .
